The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade.
Publication
, Journal Article
Roe, MT; Moliterno, DJ
Published in: Cleve Clin J Med
May 1998
Duke Scholars
Published In
Cleve Clin J Med
DOI
ISSN
0891-1150
Publication Date
May 1998
Volume
65
Issue
5
Start / End Page
267 / 272
Location
United States
Related Subject Headings
- Treatment Outcome
- Survival Analysis
- Platelet Aggregation Inhibitors
- Myocardial Ischemia
- Immunoglobulin Fab Fragments
- Humans
- Heparin
- General & Internal Medicine
- Cost-Benefit Analysis
- Anticoagulants
Citation
APA
Chicago
ICMJE
MLA
NLM
Roe, M. T., & Moliterno, D. J. (1998). The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade. Cleve Clin J Med, 65(5), 267–272. https://doi.org/10.3949/ccjm.65.5.267
Roe, M. T., and D. J. Moliterno. “The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade.” Cleve Clin J Med 65, no. 5 (May 1998): 267–72. https://doi.org/10.3949/ccjm.65.5.267.
Roe MT, Moliterno DJ. The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade. Cleve Clin J Med. 1998 May;65(5):267–72.
Roe, M. T., and D. J. Moliterno. “The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade.” Cleve Clin J Med, vol. 65, no. 5, May 1998, pp. 267–72. Pubmed, doi:10.3949/ccjm.65.5.267.
Roe MT, Moliterno DJ. The EPILOG trial. Abciximab prevents ischemic complications during angioplasty. Evaluation in PTCA to improve Long-Term Outcome with Abciximab GP IIb/IIIa Blockade. Cleve Clin J Med. 1998 May;65(5):267–272.
Published In
Cleve Clin J Med
DOI
ISSN
0891-1150
Publication Date
May 1998
Volume
65
Issue
5
Start / End Page
267 / 272
Location
United States
Related Subject Headings
- Treatment Outcome
- Survival Analysis
- Platelet Aggregation Inhibitors
- Myocardial Ischemia
- Immunoglobulin Fab Fragments
- Humans
- Heparin
- General & Internal Medicine
- Cost-Benefit Analysis
- Anticoagulants